Ophthalmology Search
Ophthalmology Ophthalmology
primary%20open-angle%20glaucoma
PRIMARY OPEN-ANGLE GLAUCOMA
Primary open-angle glaucoma (POAG) is a chronic, progressive, usually bilateral disease of the eye with an insidious onset.
It is most often characterized by optic nerve damage, defects in the retinal fiber layer and subsequent visual field loss in the absence of underlying ocular disease or congenital abnormalities.
It is generally asymptomatic until it has caused a significant loss of visual field.
Occasionally, patients with very high intraocular pressure may complain of nonspecific headache, discomfort, intermittent blurring of vision or even halos caused by corneal edema.
Drug Information

Indication: Decreased IOP in adult patients w/ open-angle glaucoma or ocular HTN for whom monotherapy provides insufficien...

Indication: Elevated IOP in ocular HTN or open-angle glaucoma.

Indication: Chronic open-angle glaucoma, ocular HTN.

Indication: Elevated IOP in patients w/ ocular HTN & open-angle glaucoma when concomitant therapy is appropriate.

Indication: Decrease of IOP in adults w/ open-angle glaucoma or ocular HTN who are insufficiently responsive to topical &b...

Indication: Elevated IOP in patients w/ ocular HTN or open-angle glaucoma.

Indication: Reduction of elevated IOP in patients w/ open-angle glaucoma, chronic angle closure glaucoma & ocular HTN;...

Indication: Reduction of IOP in patients w/ primary open-angle glaucoma or ocular HTN.

Indication: Reduction of IOP in patients w/ primary open-angle glaucoma or ocular HTN.

Indication: Elevated IOP in patients w/ ocular HTN or open-angle glaucoma.

1  /  3
1  /  3
Editor's Recommendations
Most Read Articles
Single-inhaler triple therapy effective for uncontrolled asthma
Pearl Toh, 6 days ago
Adding a LAMA* to the double combination therapy of ICS** plus LABA*** in a single inhaler improves lung function and reduces exacerbations in patients whose asthma is inadequately controlled with the combination treatment, according to the TRIMARAN and TRIGGER# studies presented at ERS 2019.
TAVI, SAVR have comparable short-, midterm safety
5 days ago
Transcatheter aortic valve implantation (TAVI) and surgical aortic valve replacement (SAVR) have comparable safety in low-risk surgical patients, reports a new meta-analysis.
Eating with friends tends to increase food intake
2 days ago
Eating alone may help in weight management as findings of a recent study suggest that eating with friends lead to higher food intake.
FLAURA reinforces osimertinib as new frontline standard for EGFRm advanced NSCLC
Elvira Manzano, 09 Oct 2019
Final overall survival (OS) results from the double-blind phase III FLAURA study reinforce osimertinib as the standard frontline treatment for epidermal growth factor receptor-mutated (EGFRm) non–small cell lung cancer (NSCLC), say leading oncologists at ESMO 2019.